Pages with the fewest revisions

From The School of Biomedical Sciences Wiki
Jump to: navigation, search

Showing below up to 500 results starting with #1.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Subst ‎(2 revisions)
  2. Gluten ‎(2 revisions)
  3. Primer ‎(2 revisions)
  4. Aluminium ‎(2 revisions)
  5. Properties of Action Potentials ‎(2 revisions)
  6. Innate immune response ‎(2 revisions)
  7. Proteoglycan ‎(2 revisions)
  8. Domain ‎(2 revisions)
  9. Sertraline ‎(2 revisions)
  10. Y-linked disorders ‎(2 revisions)
  11. Antithrombin III ‎(2 revisions)
  12. EcoR1 ‎(2 revisions)
  13. Phosphoenolpyruvate ‎(2 revisions)
  14. Ketose ‎(2 revisions)
  15. Transgenic bacteria ‎(2 revisions)
  16. Acetyl group ‎(2 revisions)
  17. Erythrocytes ‎(2 revisions)
  18. Ubiquitin-activating enzyme E3 ‎(2 revisions)
  19. Alkylation ‎(2 revisions)
  20. Glycogen synthesis ‎(2 revisions)
  21. Immunogold labelling ‎(2 revisions)
  22. Systolic pressure ‎(2 revisions)
  23. Necrotising fasciitis ‎(2 revisions)
  24. Anaerobic respiration ‎(2 revisions)
  25. Neurons ‎(2 revisions)
  26. Secondary messenger ‎(2 revisions)
  27. CFTR channel ‎(2 revisions)
  28. Flagellum ‎(2 revisions)
  29. Wuchereria bancrofti ‎(2 revisions)
  30. Canis familiaris ‎(2 revisions)
  31. Electrically exciteable cells ‎(2 revisions)
  32. Tolerance ‎(2 revisions)
  33. Corpus luteum ‎(2 revisions)
  34. High blood pressure ‎(2 revisions)
  35. Endocrine glands ‎(2 revisions)
  36. Spermatozoa ‎(2 revisions)
  37. Enzyme-linked receptors ‎(2 revisions)
  38. Leber Congenital Amaurosis ‎(2 revisions)
  39. Aerobic ‎(2 revisions)
  40. Basal bodies ‎(2 revisions)
  41. Lymphomas ‎(2 revisions)
  42. Prolactin ‎(2 revisions)
  43. Passive transporter ‎(2 revisions)
  44. TFIIA ‎(2 revisions)
  45. Growth factor receptor ‎(2 revisions)
  46. Bovine spongiform encephalopathy ‎(2 revisions)
  47. X Chromosome Inactivation ‎(2 revisions)
  48. Connexins ‎(2 revisions)
  49. Arteriole ‎(2 revisions)
  50. Photoreceptors ‎(2 revisions)
  51. Histone Acetyltransferases ‎(2 revisions)
  52. Mitogens ‎(2 revisions)
  53. Tricyclic antidepressants ‎(2 revisions)
  54. Acyl group ‎(2 revisions)
  55. Monoploidy ‎(2 revisions)
  56. Oxidative damage ‎(2 revisions)
  57. Basophils ‎(2 revisions)
  58. Eukaryotic ‎(2 revisions)
  59. Imidazole ‎(2 revisions)
  60. Amylase ‎(2 revisions)
  61. T lymphocyte ‎(2 revisions)
  62. Anomer ‎(2 revisions)
  63. Complementary base pairing ‎(2 revisions)
  64. Mesoderm ‎(2 revisions)
  65. Isoelectric Point ‎(2 revisions)
  66. Microbiota ‎(2 revisions)
  67. Elute ‎(2 revisions)
  68. Placenta ‎(2 revisions)
  69. Transgenic mice ‎(2 revisions)
  70. Cation channels ‎(2 revisions)
  71. Centromeres ‎(2 revisions)
  72. Multipotent ‎(2 revisions)
  73. Bacterial meningitis ‎(2 revisions)
  74. Myosin light chain kinase ‎(2 revisions)
  75. T-Lymphocyte ‎(2 revisions)
  76. Cis-regulatory element ‎(2 revisions)
  77. Nedd4 ‎(2 revisions)
  78. Capillaries ‎(2 revisions)
  79. Phosphoric acid ‎(2 revisions)
  80. Corticosteroids ‎(2 revisions)
  81. High density lipoproteins ‎(2 revisions)
  82. Sodium-calcium Exchanger ‎(2 revisions)
  83. Rate of reaction ‎(2 revisions)
  84. Genetic disorders ‎(2 revisions)
  85. Loci ‎(2 revisions)
  86. IPTG ‎(2 revisions)
  87. Amniocentisis ‎(2 revisions)
  88. Patau's Syndrome ‎(2 revisions)
  89. Bowman's capsule ‎(2 revisions)
  90. Female ‎(2 revisions)
  91. Termination ‎(2 revisions)
  92. Column chromatography ‎(2 revisions)
  93. Ca2+ ions ‎(2 revisions)
  94. Antigenic variation ‎(2 revisions)
  95. Heredity ‎(2 revisions)
  96. GABA receptors ‎(2 revisions)
  97. Methyl ‎(2 revisions)
  98. K+ leak channel ‎(2 revisions)
  99. Absorbance ‎(2 revisions)
  100. Pluripotent stem cells ‎(2 revisions)
  101. Epigenome ‎(2 revisions)
  102. Posterior pituitary gland ‎(2 revisions)
  103. Aliphatic ‎(2 revisions)
  104. Vaccination ‎(2 revisions)
  105. Alzheimer's ‎(2 revisions)
  106. SOS ‎(2 revisions)
  107. F-actin ‎(2 revisions)
  108. Intracellular compartment ‎(2 revisions)
  109. Tetrad ‎(2 revisions)
  110. Sex-chromosomes ‎(2 revisions)
  111. Calcium phosphate ‎(2 revisions)
  112. Frequency ‎(2 revisions)
  113. Ectoderm ‎(2 revisions)
  114. ADP ribose ‎(2 revisions)
  115. Conventional current ‎(2 revisions)
  116. Skull ‎(2 revisions)
  117. Recombinant frequency ‎(2 revisions)
  118. Autophosphorylation ‎(2 revisions)
  119. Hydrocarbon ‎(2 revisions)
  120. Mouse ‎(2 revisions)
  121. Chargaff's Rules ‎(2 revisions)
  122. Reverse primer ‎(2 revisions)
  123. Pre-Initiation Complex ‎(2 revisions)
  124. Hypotonic Solution ‎(2 revisions)
  125. Macrophages ‎(2 revisions)
  126. Voluntary movement ‎(2 revisions)
  127. Analogue ‎(2 revisions)
  128. Peptide hormones ‎(2 revisions)
  129. X-linked recessive ‎(2 revisions)
  130. Concentration Gradient ‎(2 revisions)
  131. Metals ‎(2 revisions)
  132. Zymogen ‎(2 revisions)
  133. HindIII ‎(2 revisions)
  134. Cas ‎(2 revisions)
  135. Endocrine tissue ‎(2 revisions)
  136. Plasma proteins ‎(2 revisions)
  137. Cell differentiation ‎(2 revisions)
  138. DNA methylase ‎(2 revisions)
  139. Hydroxide ‎(2 revisions)
  140. Ribonuceic acid ‎(2 revisions)
  141. Allostery ‎(2 revisions)
  142. Blastocyst ‎(2 revisions)
  143. Amoeba ‎(2 revisions)
  144. Dideoxy sequencing ‎(2 revisions)
  145. Growth hormone ‎(2 revisions)
  146. Interleukin 10 ‎(2 revisions)
  147. Personalised Healthcare ‎(2 revisions)
  148. Haworth projection ‎(2 revisions)
  149. Forward primer ‎(2 revisions)
  150. Memory B cell ‎(2 revisions)
  151. Phosphatidylethanolamine ‎(2 revisions)
  152. Threshold potential ‎(2 revisions)
  153. Consanguineous ‎(2 revisions)
  154. Herpes ‎(2 revisions)
  155. Kaposi's sarcoma ‎(2 revisions)
  156. Histone acetyltransferases ‎(2 revisions)
  157. Cytokinesis ‎(2 revisions)
  158. Oocyte ‎(2 revisions)
  159. Genomic DNA ‎(2 revisions)
  160. Polyploidy ‎(2 revisions)
  161. Light ‎(2 revisions)
  162. DNA template strand ‎(2 revisions)
  163. Dengue fever ‎(2 revisions)
  164. Immune complex ‎(2 revisions)
  165. SRY Gene ‎(2 revisions)
  166. Dilution formula ‎(2 revisions)
  167. HCN channel ‎(2 revisions)
  168. Scientific journals ‎(2 revisions)
  169. Filopodia ‎(2 revisions)
  170. Tetrasomy ‎(2 revisions)
  171. Complementary strand ‎(2 revisions)
  172. Heat shock protein ‎(2 revisions)
  173. Fructose ‎(2 revisions)
  174. Isoelectric point ‎(2 revisions)
  175. Thyroxine ‎(2 revisions)
  176. Ran ‎(2 revisions)
  177. Kidneys ‎(2 revisions)
  178. Transition metal ‎(2 revisions)
  179. Current loops ‎(2 revisions)
  180. Caveolae ‎(2 revisions)
  181. Adipocyte ‎(2 revisions)
  182. D-isomer ‎(2 revisions)
  183. Chargaff's rule ‎(2 revisions)
  184. Glucocorticoid ‎(2 revisions)
  185. Pre-eclampsia ‎(2 revisions)
  186. Hypoxanthine ‎(2 revisions)
  187. Lymph fluid ‎(2 revisions)
  188. Amino acid residues ‎(2 revisions)
  189. Parasites ‎(2 revisions)
  190. Cisternae ‎(2 revisions)
  191. Grb2 ‎(2 revisions)
  192. Boiling point ‎(2 revisions)
  193. Fasciculi ‎(2 revisions)
  194. Macula densa ‎(2 revisions)
  195. Von Gierke disease ‎(2 revisions)
  196. Secretory vesicles ‎(2 revisions)
  197. Melanocytes ‎(2 revisions)
  198. 30S ‎(2 revisions)
  199. Hemophilus influenzae ‎(2 revisions)
  200. Α-D-glucopyranose ‎(2 revisions)
  201. Cosmid ‎(2 revisions)
  202. Atomic mass ‎(2 revisions)
  203. Transpeptidase ‎(2 revisions)
  204. Sphygmomanometer ‎(2 revisions)
  205. DNA Sequencing ‎(2 revisions)
  206. Chemiluminescence ‎(2 revisions)
  207. Ribonuclease H ‎(2 revisions)
  208. Alopecia areata ‎(2 revisions)
  209. PI3Ka domain ‎(2 revisions)
  210. NAPQI ‎(2 revisions)
  211. Expect (E) value ‎(2 revisions)
  212. Lysis ‎(2 revisions)
  213. Clip ‎(2 revisions)
  214. Growth hormone releasing factor ‎(2 revisions)
  215. Nerve growth factor ‎(2 revisions)
  216. Brainstem ‎(2 revisions)
  217. Fermentation ‎(2 revisions)
  218. Anhydride ‎(2 revisions)
  219. Diuretics ‎(2 revisions)
  220. Sepsis ‎(2 revisions)
  221. X chromosomes ‎(2 revisions)
  222. Antihemophilic Factor ‎(2 revisions)
  223. Nucleous ‎(2 revisions)
  224. Lactate ‎(2 revisions)
  225. BRCA-1 ‎(2 revisions)
  226. Light dependent reaction ‎(2 revisions)
  227. Hypertrophy ‎(2 revisions)
  228. Best ‎(2 revisions)
  229. FAD ‎(2 revisions)
  230. Propyl ‎(2 revisions)
  231. Amylopectin ‎(2 revisions)
  232. Inorganic phosphate ‎(2 revisions)
  233. HDAC ‎(2 revisions)
  234. Filtrate ‎(2 revisions)
  235. Protien ‎(2 revisions)
  236. Wilson's Disease ‎(2 revisions)
  237. Anterior pituitary gland ‎(2 revisions)
  238. Intracellular receptors ‎(2 revisions)
  239. Phalanges ‎(2 revisions)
  240. Complementation ‎(2 revisions)
  241. Phospholipase A2 ‎(2 revisions)
  242. Small intestines ‎(2 revisions)
  243. Cushing sydrome ‎(2 revisions)
  244. Cdk-activating kinase ‎(2 revisions)
  245. Molecular chaperone ‎(2 revisions)
  246. Polyacrylamide ‎(2 revisions)
  247. Trisomy 8 ‎(2 revisions)
  248. DATP ‎(2 revisions)
  249. Stationary phase ‎(2 revisions)
  250. Cerebellum ‎(2 revisions)
  251. BamH1 ‎(2 revisions)
  252. Lipophilic ‎(2 revisions)
  253. P13K ‎(2 revisions)
  254. N-acetylmuramic acid ‎(2 revisions)
  255. Lymph node ‎(2 revisions)
  256. In vitro ‎(2 revisions)
  257. Negative ion ‎(2 revisions)
  258. Mad cow disease ‎(2 revisions)
  259. Walter Gilbert ‎(2 revisions)
  260. Anaphase II ‎(2 revisions)
  261. Haemolysis ‎(2 revisions)
  262. Pulmonary artery ‎(2 revisions)
  263. Antibody-antigen complex ‎(2 revisions)
  264. Drug elimination ‎(2 revisions)
  265. Metaphase I ‎(2 revisions)
  266. Phosphoryl group ‎(2 revisions)
  267. Atomic number ‎(2 revisions)
  268. Oligonucleotide ‎(2 revisions)
  269. Replication forks ‎(2 revisions)
  270. Stromatolites ‎(2 revisions)
  271. Chemiosmotic hypothesis ‎(2 revisions)
  272. Presynaptic modulation ‎(2 revisions)
  273. Ampere ‎(2 revisions)
  274. Dideoxyribose ‎(2 revisions)
  275. TFIIF ‎(2 revisions)
  276. Nerve impulse ‎(2 revisions)
  277. Mammography ‎(2 revisions)
  278. Weak acid ‎(2 revisions)
  279. Divalent metal ions ‎(2 revisions)
  280. Petri dish ‎(2 revisions)
  281. Compartmentalisation ‎(2 revisions)
  282. HeLa ‎(2 revisions)
  283. Nigrostriatal pathway ‎(2 revisions)
  284. Phosphatidylserine ‎(2 revisions)
  285. ABVD ‎(2 revisions)
  286. Carboxyl groups ‎(2 revisions)
  287. R group ‎(2 revisions)
  288. Physiotherapy ‎(2 revisions)
  289. Autocrine signalling ‎(2 revisions)
  290. Genomic library ‎(2 revisions)
  291. Postsynaptic membrane ‎(2 revisions)
  292. Oxidised ‎(2 revisions)
  293. Deoxygenated blood ‎(2 revisions)
  294. Synteny ‎(2 revisions)
  295. Chromosome walking ‎(2 revisions)
  296. FADH2 ‎(2 revisions)
  297. Dimers ‎(2 revisions)
  298. Inosine ‎(2 revisions)
  299. 'sticky' ends ‎(2 revisions)
  300. Complementation group ‎(2 revisions)
  301. Zellweger Syndrome ‎(2 revisions)
  302. Isoform ‎(2 revisions)
  303. Plant cells ‎(2 revisions)
  304. Transition state ‎(2 revisions)
  305. Celiac disease ‎(2 revisions)
  306. Molecular formula ‎(2 revisions)
  307. Progesterone only pill ‎(2 revisions)
  308. Deuterium ‎(2 revisions)
  309. T-helper cell ‎(2 revisions)
  310. Citrate carries acetyl groups ‎(2 revisions)
  311. Fats ‎(2 revisions)
  312. Disease gene ‎(2 revisions)
  313. Cofactor ‎(2 revisions)
  314. Fluorine ‎(2 revisions)
  315. Pulmonary vein ‎(2 revisions)
  316. 3q22.1 ‎(2 revisions)
  317. Hepatitis B ‎(2 revisions)
  318. Electromagnetic spectrum ‎(2 revisions)
  319. Phosphorylase ‎(2 revisions)
  320. Coupled Pumps ‎(2 revisions)
  321. Gamma rays ‎(2 revisions)
  322. Endoderm ‎(2 revisions)
  323. Plasmodium falciparum ‎(2 revisions)
  324. Transposable elements ‎(2 revisions)
  325. DNA Taq polymerase ‎(2 revisions)
  326. Orthophosphate ‎(2 revisions)
  327. Hydroxyl groups ‎(2 revisions)
  328. Strong nuclear force ‎(2 revisions)
  329. Chemistry ‎(2 revisions)
  330. Uric acid ‎(2 revisions)
  331. PMAT ‎(2 revisions)
  332. Symptom ‎(2 revisions)
  333. Vimentin ‎(2 revisions)
  334. Diet ‎(2 revisions)
  335. Closed complex ‎(2 revisions)
  336. Nerve tissue ‎(2 revisions)
  337. Saturated hydrocarbon ‎(2 revisions)
  338. Mannose ‎(2 revisions)
  339. Tertiary structure ‎(2 revisions)
  340. Nitric Oxide ‎(2 revisions)
  341. Phosphlipid ‎(2 revisions)
  342. Heterocyclic ‎(2 revisions)
  343. Crick ‎(2 revisions)
  344. Trimeric G-proteins ‎(2 revisions)
  345. Humulin ‎(2 revisions)
  346. Morphine ‎(2 revisions)
  347. Equational Division ‎(2 revisions)
  348. Linear relationship ‎(2 revisions)
  349. Postsynaptic neurone ‎(2 revisions)
  350. Alkane ‎(2 revisions)
  351. Hypoglycaemia ‎(2 revisions)
  352. Oxidising agent ‎(2 revisions)
  353. Chimerism ‎(2 revisions)
  354. Amine ‎(2 revisions)
  355. Deoxynucleoside triphosphate ‎(2 revisions)
  356. Natural killer cells ‎(2 revisions)
  357. Prostacyclin ‎(2 revisions)
  358. Vitamins ‎(2 revisions)
  359. Anabolic ‎(2 revisions)
  360. Inositiol 1,4,5 triphosphate ‎(2 revisions)
  361. HINDIII ‎(2 revisions)
  362. Neuromuscular junctions ‎(2 revisions)
  363. C-terminus ‎(2 revisions)
  364. Megakaryocytes ‎(2 revisions)
  365. Intrinsic Pathway ‎(2 revisions)
  366. Complementation test ‎(2 revisions)
  367. Sex linkage ‎(2 revisions)
  368. Fugu Rubripes ‎(2 revisions)
  369. Metabolic processes ‎(2 revisions)
  370. Quiescence ‎(2 revisions)
  371. Isolating DNA ‎(2 revisions)
  372. G protein (Gs) ‎(2 revisions)
  373. Randomised controlled trials ‎(2 revisions)
  374. Acidity ‎(2 revisions)
  375. Reduction ‎(2 revisions)
  376. Trisomys ‎(2 revisions)
  377. DGTP ‎(2 revisions)
  378. Retinitis pigmentosa ‎(2 revisions)
  379. Charges ‎(2 revisions)
  380. Muscle Twitch ‎(2 revisions)
  381. Lipoprotein ‎(2 revisions)
  382. IGF (Insulin Growth Factor) ‎(2 revisions)
  383. Cholecystokinin ‎(2 revisions)
  384. Biochemistry ‎(2 revisions)
  385. Aminoacyl ‎(2 revisions)
  386. Incomplete dominance ‎(2 revisions)
  387. Parathyroid gland ‎(2 revisions)
  388. Citric Acid Cycle ‎(2 revisions)
  389. Gregory Mendel ‎(2 revisions)
  390. Protein coding genes ‎(2 revisions)
  391. Androgen ‎(2 revisions)
  392. Insulin receptor substrate ‎(2 revisions)
  393. Selenocysteine ‎(2 revisions)
  394. X-ray diffraction ‎(2 revisions)
  395. DsRNA ‎(2 revisions)
  396. Phosphatases ‎(2 revisions)
  397. Tracheotomy ‎(2 revisions)
  398. Histamine receptors ‎(2 revisions)
  399. Recepter Tyrosine Kinases ‎(2 revisions)
  400. Endogenous ‎(2 revisions)
  401. Active immunity ‎(2 revisions)
  402. Aldose ‎(2 revisions)
  403. Hydroxylation ‎(2 revisions)
  404. Structural formula ‎(2 revisions)
  405. Primary alcohol ‎(2 revisions)
  406. Uridine ‎(2 revisions)
  407. Dehydration ‎(2 revisions)
  408. Promoters ‎(2 revisions)
  409. Patch clamp techniques ‎(2 revisions)
  410. Bromelain ‎(2 revisions)
  411. Protein sequence ‎(2 revisions)
  412. Animal cells ‎(2 revisions)
  413. Calcitonin ‎(2 revisions)
  414. Xenophagy ‎(2 revisions)
  415. Thymidine ‎(2 revisions)
  416. Rab ‎(2 revisions)
  417. Keratinocytes ‎(2 revisions)
  418. Open state probability ‎(2 revisions)
  419. Centric fusion ‎(2 revisions)
  420. Restriction digests ‎(2 revisions)
  421. DNA transcription ‎(2 revisions)
  422. Chiral ‎(2 revisions)
  423. Valvular Heart Disease ‎(2 revisions)
  424. Amine group ‎(2 revisions)
  425. Deoxynucleotide ‎(2 revisions)
  426. Immunoblotting ‎(2 revisions)
  427. Synthetic ‎(2 revisions)
  428. Chronic myeloid leukaemia ‎(2 revisions)
  429. Anti-serum ‎(2 revisions)
  430. Pharmacokinetics ‎(2 revisions)
  431. Microtubule motor protein ‎(2 revisions)
  432. Cerebrum ‎(2 revisions)
  433. Multidrug resistance ‎(2 revisions)
  434. Rous sarcoma ‎(2 revisions)
  435. Aminoacyl-tRNA synthase ‎(2 revisions)
  436. Induced Pluripotent stem cell ‎(2 revisions)
  437. T4 phage ‎(2 revisions)
  438. Fatty acid chain ‎(2 revisions)
  439. Protein crystallization ‎(2 revisions)
  440. Hairpin ‎(2 revisions)
  441. Neutrophils ‎(2 revisions)
  442. Self splicing ‎(2 revisions)
  443. Foetus ‎(2 revisions)
  444. Purine ‎(2 revisions)
  445. X-rays ‎(2 revisions)
  446. Non-sister chromatids ‎(2 revisions)
  447. Jejunum ‎(2 revisions)
  448. Endomembrane system ‎(2 revisions)
  449. Pleckstrin homology ‎(2 revisions)
  450. Cystic fibrosis transmembrane regulator ‎(2 revisions)
  451. Host cell ‎(2 revisions)
  452. Spindle assembly checkpoint ‎(2 revisions)
  453. Genetic sequence ‎(2 revisions)
  454. B-Lymphocyte ‎(2 revisions)
  455. Epidermal growth factor ‎(2 revisions)
  456. Tuberculin Test ‎(2 revisions)
  457. Hydrolytic enzymes ‎(2 revisions)
  458. Uridine Diphosphate Glucose (UDP-glucose) ‎(2 revisions)
  459. Virion ‎(2 revisions)
  460. Amphipathic molecule ‎(2 revisions)
  461. Fibroblast ‎(2 revisions)
  462. Serology ‎(2 revisions)
  463. Xenopus ‎(2 revisions)
  464. ADH ‎(2 revisions)
  465. Catastrophe ‎(2 revisions)
  466. Recessive phenotype ‎(2 revisions)
  467. Staphylococci ‎(2 revisions)
  468. Positive charge ‎(2 revisions)
  469. Van der Waals forces ‎(2 revisions)
  470. Nausea ‎(2 revisions)
  471. Voltage ‎(2 revisions)
  472. Tandem repeats ‎(2 revisions)
  473. Composition of prokaryotic ribosome ‎(2 revisions)
  474. Hematopoietic stem cells ‎(2 revisions)
  475. Sexual reproduction ‎(2 revisions)
  476. Efficacy ‎(2 revisions)
  477. Isomer ‎(2 revisions)
  478. High Altitude Cerebral Edema ‎(2 revisions)
  479. Enantiomers ‎(2 revisions)
  480. Plaque ‎(2 revisions)
  481. Acromegaly ‎(2 revisions)
  482. Sperm ‎(2 revisions)
  483. Leaky junction ‎(2 revisions)
  484. Polygenic ‎(2 revisions)
  485. Checkpoint pathways ‎(2 revisions)
  486. Glucose-1-phosphate ‎(2 revisions)
  487. Unipotent ‎(2 revisions)
  488. IL-6 ‎(2 revisions)
  489. P53 gene ‎(2 revisions)
  490. Surival Factors ‎(2 revisions)
  491. Rubidium ‎(2 revisions)
  492. Exonuclease ‎(2 revisions)
  493. Induced fit mechanism ‎(2 revisions)
  494. TATA-binding protein ‎(2 revisions)
  495. Group 1 metals ‎(2 revisions)
  496. Sanger Method ‎(2 revisions)
  497. Nick ‎(2 revisions)
  498. Purines ‎(2 revisions)
  499. Hepatocytes ‎(2 revisions)
  500. Non-steroidal anti-inflammatory drugs ‎(2 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

Personal tools
Namespaces
Variants
Views
Actions
Navigation
Toolbox